The quote I liked from Dr Duthy was where he said the fact there have been no side effects and he has seen such significant progress in his patients.
If the phase II/III trial is going the same way....would have to assume it is....then this company could really be onto something even just for an autism treatment.
Ann: Neurotech Receives Additional HREC Approval in Autism, page-3
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.001(1.64%) |
Mkt cap ! $63.07M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.4¢ | 6.1¢ | $89.72K | 1.425M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103473 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 70617 | 1 |
View Market Depth
| Last trade - 15.23pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
0.001 ( 3.28 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 6.4¢ | 6.2¢ | 486091 | ||
| Last updated 15.58pm 17/06/2024 ? | |||||
| NTI (ASX) Chart |
